Technical Data
ARF5 (ADP-ribosylation Factor 5) (FITC)
GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP-ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus.

Suitable for use in FLISA and Western Blot. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20C. Aliquots are stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. FITC conjugates are sensitive to light.
100ug-20CBlue IceHumanRabbit
As reported
Recombinant corresponding to human ADP-ribosylation factor 5.
Purified by ammonium sulfate precipitation.
Supplied as a liquid in PBS. Labeled with fluorescein isothiocyanate (FITC).
Recognizes human ARF5.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. "Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells." Tsuchiya M., Price S.R., Tsai S.-C., Moss J., Vaughan M. J. Biol. Chem. 266:2772-2777 (1991). 2. "Localization and characterization of the human ADP-ribosylation factor 5 (ARF5) gene." McGuire R.E., Daiger S.P., Green E.D. Genomics 41:481-484 (1997). 3. "cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (" Puhl H.L. III, Ikeda S.R., Aronstam R.S.